EIKN compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

EIKNEikon Therapeutics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

EIKNEikon Therapeutics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

EIKNEikon Therapeutics, Inc.

5.42▼−2.42%

Mkt cap$307.5MRevenue—Revenue—

AMGNAmgen Inc

474.06▲+2.77%

Regular sessionNov 4 '26

Mkt cap$249.4BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

Regular sessionNov 4 '26

EIKNEikon Therapeutics, Inc.

AMGNAmgen Inc

5.42▼−2.42%

Price

474.06▲+2.77%

$307.5M

Mkt cap

$249.4B

—

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

EIKN5.42▼−2.42%vsAMGN474.06▲+2.77%Regular sessionNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

EIKN: latest quarter not drawable.Method ›

Price

rebased to 0%

EIKN, solidAMGN, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only EIKN 4

MRKMSD International Business GmbHsupplier

—Impact Therapeutics (Shanghai)unlistedsupplier

—Seven and Eight Biotherapeuticsunlistedsupplier

—Superb Wisdomunlistedsupplier

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›